Rise Above with the Down-Under Advantage
Partner with Complete Phase to accelerate your Phase 1/2 studies, optimize budgets, and leverage Australia's streamlined regulatory environment, all while working directly with senior-level professionals committed to your success.
Get Your Free Strategic Consultation
Experts in Early-Phase Clinical Trial Services
Complete Phase is a specialised clinical development partner purpose-built for small to mid-sized biotech and pharma companies. We offer a smarter, more flexible alternative to large CROs – with the agility, expertise, and personal attention your early-phase program deserves.
QUALITY
Led by highly seasoned industry leaders with average 20 plus years experience, our organisation excels in executing successful clinical trials across multiple therapeutic areas.
PARTNERSHIP
Operating as strategic partners, we prioritise client satisfaction and success through proactive communication, anticipating needs, and identifying opportunities.
CUSTOMIZATION
As an agile team, we provide customised solutions tailored to specific client needs. Being nimble, we swiftly initiate projects, iterate efficiently, and deliver to every expectation.
This is a Hands-On Partnership, Not a Transactional Vendor
Get Direct Access to Experienced Professionals:
You'll collaborate one-on-one with senior clinical operations experts who act as an extension of your team rather than navigating multiple layers of red tape.
Responsive, Agile, and Invested:
Our flat structure ensures rapid decision-making and personalized attention—critical for small biotech and pharma teams that need nimble support.
Built for End-to-End Early-Phase Success
With dozens of Phase 1/2 trials executed across Australia and New Zealand, our team understands the unique challenges of first-in-human and proof-of-concept studies. From protocol development and ethics submissions to site selection and closeout reviews, we guide every stage of your early-phase program.
Deep Therapeutic Knowledge
With a rich suite of therapeutic competencies and foci, including a specialty in infection and inflammatory diseases, our team can help you navigate and leverage an array of indications at multiple stages of your early-phase trial.
Get Ahead with The Australian Advantage
You may be wondering why an American study should be conducted on Australian soil. Our government-backed R&D Tax Incentive can reimburse up to 43.5% of eligible clinical trial expenses for US sponsors conducting study start-up through Australian CROs.
Not only that, but accelerated regulatory requirements Down Under mean we can get you from ethics submission to study launch in only 4 weeks.
Basically, you slash your net costs while securing ethics approval in just four weeks to reach first subject faster; with our boutique, hands-on team and rich clinical expertise, your early-stage program gets the scientifically rigorous, specialized support it needs.
R&D Tax Incentive
Government-backed reimbursement for eligible clinical trial expenses
Weeks to Launch
From ethics submission to study start - accelerated regulatory timeline
Complete-Phase Services At A Glance
Our three-phase process moves your study strategically from planning to execution to review, covering everything from site selection and protocol finalization to coordinated site enrollment to a final debrief call to optimize next-phase transition.
| Service Area | Key Features |
|---|---|
| Protocol Design & Regulatory Strategy |
|
| Clinical Operations & Project Management |
|
| Biometrics & Data Management |
|
| Medical Affairs & Pharmacovigilance |
|
| Local Sponsorship & Incentive Facilitation |
|
Still on the Fence?
Explore our website or get in touch with a Complete-Phase expert to learn more about what our team can do for your trial.
Ready to Get Started?
Contact our team today to discuss how Complete Phase can accelerate your Phase 1/2 clinical trials with the Australian advantage.